FMR CORP 13D and 13G filings for MoonLake Immunotherapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:30 am Purchase |
2024-12-31 | 13G | MoonLake Immunotherapeutics MLTX |
FMR CORP | 6,306,391 10.000% |
1,365,267 (+27.63%) |
Filing |
| 2024-11-12 10:32 am Purchase |
2024-11-08 | 13G | MoonLake Immunotherapeutics MLTX |
FMR CORP | 4,941,124 7.856% |
1,093,447 (+28.42%) |
Filing |
| 2024-02-09 09:28 am Purchase |
2024-02-08 | 13G | MoonLake Immunotherapeutics MLTX |
FMR CORP | 3,847,677 6.419% |
2,654,677 (+222.52%) |
Filing |
| 2023-02-09 12:48 pm Purchase |
2023-02-09 | 13G | MoonLake Immunotherapeutics MLTX |
FMR CORP | 1,193,000 3.230% |
1,193,000 (New Position) |
Filing |